Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOAD C-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody

Citation
H. Miyakawa et al., Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOAD C-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent anti-mitochondrial antibody, HEPATOL RES, 18(1), 2000, pp. 1-9
Citations number
26
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
HEPATOLOGY RESEARCH
ISSN journal
13866346 → ACNP
Volume
18
Issue
1
Year of publication
2000
Pages
1 - 9
Database
ISI
SICI code
1386-6346(200007)18:1<1:AOTMAA>2.0.ZU;2-X
Abstract
To analyze anti-M2 components in primary biliary cirrhosis (PBC) we measure d two major anti-M2 antibodies (anti-PDC-E2 and anti-BCOADC-E2) by immunobl otting and ELISA, and compared the results between 38 immunofluorescent ant i-mitochondrial antibody (AMA)-negative PBC patients (group A) and 39 stron gly AMA-positive PBC patients (group B) with titers of 1:640. Using bovine heart mitochondrial fraction as antigen, the immunoblot positivity rate of anti-PDC-E2 in group B was significantly higher than that in group A, where as the positivity rate of anti-BCOADC-E2 was not significantly different be tween the two groups. This result was similar to that obtained by ELISA usi ng recombinant fusion proteins. In group A there was a significant inverse correlation between ELISA optical density values of anti-PDC-E2 and of anti -BCOADC-E2, but in group B there was no correlation between the two values. Only three patients from group A and 21 from group B were positive for bot h antibodies. Taken together these results appear to indicate that the dete ction of anti-BCOADC-E2 is critical for the accurate serological diagnosis of AMA-negative PBC patients. The detection of anti-BCOADC-E2 may also help to distinguish between AMA-negative PBC and autoimmune cholangitis patient s. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.